FDA Class I recall: Medline procedure kits containing Huons bupivacaine pulled in chain recall

This recall stems not from the design or manufacture of the kit itself, but from a single component packed inside it. "Bupivacaine" is a local anesthetic used to control pain during surgery or procedures, and here it was included in the kits as an injectable. The Huons-made injection was recalled first over quality issues including microbiology testing, and the Medline procedure kits containing it were then pulled in turn. Class I, the most serious of the FDA's recall classifications, is used when there is a reasonable probability that use of the product could cause serious health consequences or death.

The case illustrates a risk specific to the "kit" product format, in which several components are bundled together. Kits make clinical work more convenient by gathering needed items in one package, but if even one component has a quality problem, the entire kit containing it becomes unusable and the recall widens to cover it. In fact, Medline kit recalls from the same root cause spanned multiple records (Z-2231 through Z-2237 in the filings), totaling on the order of hundreds of thousands of kits. A quality issue in a single injectable thus propagated across many finished products.

In medical device and pharmaceutical supply chains, the company that assembles the finished product (here, Medline) and the company that supplies a component (here, Huons) are commonly separate. The finished-product maker remains responsible for the quality of components it did not manufacture, and once a problem at the supplier is identified it must trace and recall its own products promptly. This event concretely shows how component-level quality control and lot traceability govern the safety of the finished product as a whole.